Prostate development and growth in benign prostatic hyperplasia.

Differentiation

Division of Basic Biomedical Sciences, Sanford School of Medicine, The University of South Dakota, 414. E. Clark St., Vermillion, SD 57069, USA.

Published: January 2012

The etiology of benign prostatic hyperplasia [BPH] in elderly men has intrigued anatomists, pathologists and scientists for centuries. Studies of morbid anatomy, clinical observations and contemporary cellular biology have contributed to an evolving interpretation of the causality of the disease. Insights into the detailed microanatomy and ductal architecture of the prostate during stages of fetal and early postnatal development suggest that mechanisms involved in the early growth period become aberrantly expressed in elderly men. Age, hormones and epithelial-mesenchymal interactions are all contributing factors to the pathogenesis of BPH. Control of the microenvironment in normal and abnormal growth is a multifactorial process. Susceptibility to the disease may include clinical comorbid diseases, region-specific changes in cell-cell interactions and a variety of signaling pathways including a novel hypothesis regarding the role of the primary cilium as a regulator of signal transduction mechanisms. Recent work in animal models has shown that there are region-specific differences within the prostate that may be significant because of the dynamic and intricate interplay between the epithelium and mesenchyme. Because of the focal nature of BPH a closer examination of normal morphogenesis patterns, which defines the gland's architecture, may facilitate a detailed understanding of the atypical growth patterns.

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.diff.2011.08.002DOI Listing

Publication Analysis

Top Keywords

benign prostatic
8
prostatic hyperplasia
8
elderly men
8
prostate development
4
growth
4
development growth
4
growth benign
4
hyperplasia etiology
4
etiology benign
4
hyperplasia [bph]
4

Similar Publications

Prostate cancer (PC) progresses from benign epithelium through pre-malignant lesions, localized tumors, metastatic dissemination, and castration-resistant stages, with some cases exhibiting phenotype plasticity under therapeutic pressure. However, high-resolution insights into how cell phenotypes evolve across successive stages of PC remain limited. Here, we present the Prostate Cancer Cell Atlas (PCCAT) by integrating ∼710,000 single cells from 197 human samples covering a spectrum of tumor stages.

View Article and Find Full Text PDF

Background: Currently, serum PSA is the most commonly used screening tool in clinical practice. However, PSA levels in the range of 4-10 ng/ml are considered the 'grey zone' of prostate cancer screening. Patients within this range need to be further evaluated using additional parameters such as PSA ratio, PSA density, and other indices to determine the necessity of prostate biopsy (PBx).

View Article and Find Full Text PDF

Background: Male pattern baldness (MPB) is commonly associated with prostate diseases, both of which can significantly impact men's quality of life. However, the relationship and causality between them remain unclear. In this study, we investigated the causal relationship between the two.

View Article and Find Full Text PDF

Aim/Objective The aim of this study was to investigate if diffuse, bilateral PI-RADS (Prostate Imaging Reporting and Data System) 3 changes, reported on MRI Prostate, harbour clinically significant prostate cancer (csPCa) within them. Methods Data from 108 men with diffuse, bilateral PI-RADS 3 changes on MRI of the prostate who underwent systematic prostate biopsy between January 2000 and November 2023 were analyzed. Histology results were classified as benign or malignant, and clinically significant prostate cancer (csPCa) was defined according to the European Association of Urology (EAU) guidelines as ISUP GG (International Society for Urological Pathology Grade Group) 2 or higher.

View Article and Find Full Text PDF

Background: Early diagnosis of prostate cancer can improve the survival rate of patients on the premise of high-quality images. The prerequisite for early diagnosis is high-quality images. ZOOMit is a method for high-resolution, zoomed FOV imaging, allowing diffusion-weighted images with high contrast and resolution in short acquisition times.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!